Pancreatic Adenocarcinoma Gene Environment Risk Study

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT00912717
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.

Key Dates

Start date
Jan 31, 2004
Status verified
Nov 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Pancreatic Cancer
    individuals who have been diagnosed with pancreatic cancer
  • Arm: Unaffected
    individuals who have not been diagnosed with pancreatic cancer

Primary Outcome Measure

The data will be used in cohort association studies. Endpoints will depend on the number of patients in the study and the number of markers that are being evaluated. [ Time Frame: 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of PittsburghPittsburghPennsylvania15213
Randall E Brand, MD
[email protected]
412-623-3105

Find similar trials in Pittsburgh, PA

By condition
Pancreatic cancer
By specialty
OncologyGI oncology
By research site
University of Pittsburgh· Pittsburgh, PA

Related Studies